| | Class 2 Device Recall Vascular Dilator |  |
| Date Initiated by Firm | May 02, 2018 |
| Create Date | July 27, 2018 |
| Recall Status1 |
Terminated 3 on July 20, 2020 |
| Recall Number | Z-2559-2018 |
| Recall Event ID |
80021 |
| Product Classification |
Cadiovascular, Introducer catheter - Product Code DYB
|
| Product | 1) Vascular Dilator, Sterile EO, Rx Only, Catalog #: DIL-100-12;
2) Dilator, Sterile EO, Rx Only, Catalog #: DIL-600-11;
3) Tearaway Introducer, Sterile EO, Rx Only, Catalog #: a) INT-028-14; b) INT-028-24; c) INT-029-05; d) INT-106-01; e) INT-106-14;
4) Micro-Access Tearaway Introducer Kit, Sterile EO, Rx Only, Catalog #: KIT-010-14;
5) Mini Tear Away Introducer Kit, Sterile EO, Rx Only, Catalog #: KIT-027-04;
6) LI-11 Plus G, Sterile EO, Catalog #: KIT-042-11;
7) LI-12 Plus G, Sterile EO, Catalog #: KIT-042-12;
8) Micro-Access Tearaway Introducer Kit, Sterile EO, Catalog #: a) KIT-900-13; b) KIT-900-14; c) KIT-900-17; d) KIT-900-29; e) KIT-901-02; f) KIT-901-02;
9) "Micro-Access" Kit, Sterile EO, Catolog #: KIT-900-88
10) Mini Stick II Microintroducer Kit. Sterile EO, Rx Only, Catalog #: a) KIT-045-05; b) KIT-045-15; |
| Code Information |
lot #: 1) 18102478; 2) 18033450; 3) a) 18089973; b) 18031311; c) 18046318; d) 18082001; e) 18040777, 18061334; 4) S17342075; 5) P18015009; 6) S18051159, S18072306; 7) S18072307; 8) a) S18033049, S18064105, S18093202, S18096316; b) S18025037, S18032055, S18032100, S18032101, S18093199, S18096314; c) S18093200; d) S18032056, S18032102, S18052063, S18074161, S18093203, S18096318; e) S18064104, S18093201; f) S18096315; 9) S18018008; 10) a) G18012001, G18064125; b) S18017001 |
Recalling Firm/ Manufacturer |
Galt Medical Corporation 2220 Merritt Dr Garland TX 75041-6137
|
| For Additional Information Contact | David Derrick 214-778-1306 |
Manufacturer Reason for Recall | The products listed might contain unsafe levels of bacterial endotoxins (Pyrogens) that were introduced during a manufacturing step. Bacterial Endotoxins also called pyrogenic bacteria can activate the inflammatory process and produce fever, chills, and hypotension in a patient. |
FDA Determined Cause 2 | Other |
| Action | On approximately 05/01/2018 recall letters and customer response forms were mailed to all consignees. |
| Quantity in Commerce | 9050 |
| Distribution | U.S.: MN, PA, VA, CA, UT, FL, NY, GA, LA, MO, TX, MS, OH, WA, MA, IL, KY, NC, and Puerto Rico;
OUS: Canada, Australia, France, Germany, Ireland, Italy, Netherlands, Poland, Slovakia, Switzerland, Belgium, United Kingdom, Korea |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|